By Therapeutic Area

Cardiovascular & Rare Disease Market Analysis

Cross-industry research covering Cardiovascular & Rare Disease across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports

1 Industries

Reports Covering Cardiovascular & Rare Disease

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Rare disease carrier screening panels (spinal muscular atrophy, cystic fibrosis, fragile X) and cardiovascular risk panels (HCM, ARVC) occupy a medically serious niche that commands premium pricing and tends toward physician-ordered rather than pure DTC channels.

10%

Market Share

8.4%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments